‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court

Appeals 2019-02-25 1:34 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant’s appeal “misconceived”.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au